126 related articles for article (PubMed ID: 38580136)
1. Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response.
Zhao M; He C; Zheng X; Jiang M; Xie Z; Wei H; Zhang S; Lin Y; Zhang J; Sun X
J Control Release; 2024 May; 369():556-572. PubMed ID: 38580136
[TBL] [Abstract][Full Text] [Related]
2. Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation.
Xi X; Zhang L; Lu G; Gao X; Wei W; Ma G
J Immunol Res; 2018; 2018():3714960. PubMed ID: 30018987
[TBL] [Abstract][Full Text] [Related]
3. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
[TBL] [Abstract][Full Text] [Related]
4. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
[TBL] [Abstract][Full Text] [Related]
5. Dual-Responsive Glycopolymers for Intracellular Codelivery of Antigen and Lipophilic Adjuvants.
De Mel J; Hossain M; Shofolawe-Bakare O; Mohammad SA; Rasmussen E; Milloy K; Shields M; Roth EW; Arora K; Cueto R; Tang SC; Wilson JT; Smith AE; Werfel TA
Mol Pharm; 2022 Dec; 19(12):4705-4716. PubMed ID: 36374992
[TBL] [Abstract][Full Text] [Related]
6. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response.
Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D
Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734
[TBL] [Abstract][Full Text] [Related]
7. Modular core-shell polymeric nanoparticles mimicking viral structures for vaccination.
Lou B; De Beuckelaer A; Boonstra E; Li D; De Geest BG; De Koker S; Mastrobattista E; Hennink WE
J Control Release; 2019 Jan; 293():48-62. PubMed ID: 30428307
[TBL] [Abstract][Full Text] [Related]
8. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.
Baljon JJ; Kwiatkowski AJ; Pagendarm HM; Stone PT; Kumar A; Bharti V; Schulman JA; Becker KW; Roth EW; Christov PP; Joyce S; Wilson JT
ACS Nano; 2024 Mar; 18(9):6845-6862. PubMed ID: 38386282
[TBL] [Abstract][Full Text] [Related]
9. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
[TBL] [Abstract][Full Text] [Related]
10. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.
Wilson JT; Keller S; Manganiello MJ; Cheng C; Lee CC; Opara C; Convertine A; Stayton PS
ACS Nano; 2013 May; 7(5):3912-25. PubMed ID: 23590591
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous ZnO nanocapsules for the induction of enhanced antigen-specific immunological responses.
Afroz S; Medhi H; Maity S; Minhas G; Battu S; Giddaluru J; Kumar K; Paik P; Khan N
Nanoscale; 2017 Oct; 9(38):14641-14653. PubMed ID: 28936523
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
[TBL] [Abstract][Full Text] [Related]
13. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.
Liu J; Liu X; Han Y; Zhang J; Liu D; Ma G; Li C; Liu L; Kong D
ACS Appl Mater Interfaces; 2018 Sep; 10(37):30983-30993. PubMed ID: 30136844
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
Mosaheb M; Wetzler LM
Vaccine; 2018 Nov; 36(50):7689-7699. PubMed ID: 30381152
[TBL] [Abstract][Full Text] [Related]
15. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
16. Self-adjuvanting cancer nanovaccines.
Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K
J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176
[TBL] [Abstract][Full Text] [Related]
17. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannan.
Roque JA; Lukesh NR; Hendy DA; Dixon TA; Islam MJ; Ontiveros-Padilla L; Pena ES; Lifshits LM; Simpson SR; Batty CJ; Bachelder EM; Ainslie KM
Int J Pharm; 2024 May; 656():124076. PubMed ID: 38569976
[TBL] [Abstract][Full Text] [Related]
19. The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice.
Cuzzubbo S; Banissi C; Rouchon MS; Tran T; Tanchot C; Tartour E; Carpentier AF
Cancer Immunol Immunother; 2020 Dec; 69(12):2501-2512. PubMed ID: 32561966
[TBL] [Abstract][Full Text] [Related]
20. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
